(Q28282770)

English

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Tobias Banaschewski

3

0 references

4

0 references

object named as

David Coghill

5

0 references

Samuele Cortese

object named as

Samuele Cortese

1

0 references

Ralf W. Dittmann

7

object named as

Ralf W Dittmann

0 references

Martin Holtmann

2

object named as

Martin Holtmann

0 references

Marina Danckaerts

6

object named as

Marina Danckaerts

0 references

author name string

John Graham

8

0 references

Eric Taylor

9

0 references

Joseph Sergeant

10

0 references

language of work or name

0 references

publication date

March 2013

0 references

The Journal of Child Psychology and Psychiatry

0 references

54

0 references

3

0 references

227-46

0 references

Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Depression and suicide in adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Meta-analysis of suicide-related behavior events in patients treated with atomoxetine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hallucinations associated with initiation of guanfacine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD drugs and serious cardiovascular events in children and young adults

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine abuse among opiate addicts

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

New-onset seizures: a possible association with clonidine?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sudden death and use of stimulant medications in youths.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

European guidelines on managing adverse effects of medication for ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Increased frequency of rolandic spikes in ADHD children

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Pharmacological treatment of ADHD and the short and long term effects on sleep

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Abuse liability assessment of atomoxetine in a drug-abusing population

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sleep and ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Critical review of data supporting affective disorder caused by nonpsychotropic medication

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does guanfacine cause hallucinations in children?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The use, misuse and diversion of prescription stimulants among middle and high school students.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Growth on stimulant medication; clarifying the confusion: a review

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiovascular events and death in children exposed and unexposed to ADHD agents

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD treatments, sleep, and sleep problems: complex associations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The intersection of attention-deficit/hyperactivity disorder and substance abuse

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28282770&oldid=1971929093"